Kopans: Attacks on mammography are part of coordinated effort -- References

Apr 27, 2014

Biller-Andorno N, Jüni P. Abolishing mammography screening programs? A view from the Swiss Medical Board [published online ahead of print April 16, 2014]. NEJM. 2014. http://www.nejm.org/doi/full/10.1056/NEJMp1401875.
Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty-five-year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: Randomised screening trial. BMJ. 2014;348:g366. http://www.bmj.com/content/348/bmj.g366.
Kopans DB. The Canadian screening program: A different perspective. AJR. 1990;155(4):748-749.
Yaffe MJ. Correction: Canada study. Letter to the Editor. J Natl Cancer Inst. 1993;85(2):94.
Kopans DB, Feig SA. The Canadian National Breast Screening Study: A critical review. AJR Am J Roentgenol. 1993;161(4):755-760.
Tarone RE. The excess of patients with advanced breast cancers in young women screened with mammography in the Canadian National Breast Screening Study. Cancer. 1995;75(4):997-1003.
Bailar JC, MacMahon B. Randomization in the Canadian National Breast Screening Study: A review for evidence of subversion. Can Med Assoc J. 1997;156(2):193-199.
Screening mammography in women aged 40-49: A report of the American College of Physicians and American College of Radiology consensus meeting. ACP Internist website. http://www.acpinternist.org/archives/2012/05/policy.htm. February 21, 2012. Accessed September 9, 2012.
Hendrick RE, Helvie MA. United States Preventive Services Task Force screening mammography recommendations: Science ignored. AJR Am J Roentgenol. 2011;196(2):W112-W116.
Kopans DB. The U.S. Preventive Services Task Force guidelines are not supported by the scientific evidence. Radiology. 2010;257(1):294-295.
Quanstrum KH, Hayward RA. Lessons from the mammography wars. NEJM. 2010;363(11):1076-1079.
The editors. When evidence collides with anecdote, politics, and emotion: Breast cancer screening. Ann Intern Med. 2010;152(8):531-532. .
Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363(13):1203-1210.
Hofvind S, Ursin G, Tretli S, Sebuødegård S, Møller B. Breast cancer mortality in participants of the Norwegian breast cancer screening program. Cancer. 2013;119(17):3106-3112.
Bleyer A, Welch HG. Effect of three decades of screening mammography on breast cancer incidence. N Engl J Med. 2012;367(21):1998-2005.
Welch HG. Cancer survivor or victim of overdiagnosis? New York Times. November 21, 2012. http://www.nytimes.com/2012/11/22/opinion/cancer-survivor-or-victim-of-overdiagnosis.html.
Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Intern Med. 2014;174(3):448-454.
Welch HG. Breast cancer screenings: What we still don't know. New York Times. December 29, 2013. http://www.nytimes.com/2013/12/30/opinion/breast-cancer-screenings-what-we-still-dont-know.html.
Harris R. Screening is only part of the answer to breast cancer [published online ahead of print April 8, 2014]. Ann Intern Med. 2008. http://annals.org/article.aspx?articleID=1859302.
Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311(13):1327-1335.
Advisory board. Nordic Cochrane Centre website. http://www.cochrane.dk/about/advboard.htm. Updated February 25, 2014. Accessed April 5, 2014.
Gøtzsche PC. Time to stop mammography screening? CMAJ. 2011;183(17):1957-1958.
Freedman DA, Petitti DB, Robins JM. On the efficacy of screening for breast cancer. Int J Epidemiol. 2004;33(1):43-55.
Health Council of the Netherlands: The benefit of population screening for breast cancer with mammography. The Hague: Health Council of the Netherlands, 2002; publication no. 2002/03E.
Duffy SW, Tabár L, Smith RA. The mammographic screening trials: Commentary on the recent work by Olsen and Gøtzsche. CA A Cancer J Clin. 2002;52(2):68-71.
Kopans DB. The most recent breast cancer screening controversy about whether mammographic screening benefits women at any age: Nonsense and nonscience. AJR Am J Roentgenol. 2003;180(1):21-26.
Bock K, Borisch B, Cawson J, et al. Effect of population-based screening on breast cancer mortality. Lancet. 2011;19;378(9805):1775-1776.